A phase I study of temsirolimus plus carboplatin plus paclitaxel for patients with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC).
about
Parallel phase Ib studies of two schedules of buparlisib (BKM120) plus carboplatin and paclitaxel (q21 days or q28 days) for patients with advanced solid tumors.A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancer.A phase II study of temsirolimus and erlotinib in patients with recurrent and/or metastatic, platinum-refractory head and neck squamous cell carcinomaHead and neck cancer: from anatomy to biology.Novel treatments for head and neck squamous cell carcinoma: preclinical identification and clinical investigation.Development and Validation of an Inductively Coupled Plasma Mass Spectrometry (ICP-MS) Method for Quantitative Analysis of Platinum in Plasma, Urine, and Tissues.Carboplatin synergistically triggers the efficacy of photodynamic therapy via caspase 3-, 8-, and 12-dependent pathways in human anaplastic thyroid cancer cells.Investigational drugs for head and neck cancer.A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).[Therapy of recurrent or metastatic head and neck squamous cell carcinoma : highlights of the ASCO Meeting 2014].
P2860
Q27853128-3B733E62-E612-495B-9910-2DBD9E84ABD6Q33405880-9F711FF1-4332-485C-B25A-845755D200AEQ37248229-4E66E647-9ECA-4C8B-957C-ACF27C9B2487Q38082457-6D241A72-E3D3-4B94-943D-3EAFC98B3850Q38221292-C81C1343-284A-4B5E-8235-5416EB1A4C78Q38436491-0B44A757-5EB4-4B02-8951-4D30DEBC7427Q38446206-6423FC93-6F74-4742-B157-C2EE4945A680Q38800788-D07BAB71-DA11-497E-B3DD-4132AF1DBC87Q41928624-6475F296-773B-4A49-B3EF-A8797DC66A75Q51261062-B0B73819-D381-4AB3-888B-86DBCC326188
P2860
A phase I study of temsirolimus plus carboplatin plus paclitaxel for patients with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC).
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
A phase I study of temsirolimu ...... squamous cell cancer (HNSCC).
@ast
A phase I study of temsirolimu ...... squamous cell cancer (HNSCC).
@en
type
label
A phase I study of temsirolimu ...... squamous cell cancer (HNSCC).
@ast
A phase I study of temsirolimu ...... squamous cell cancer (HNSCC).
@en
prefLabel
A phase I study of temsirolimu ...... squamous cell cancer (HNSCC).
@ast
A phase I study of temsirolimu ...... squamous cell cancer (HNSCC).
@en
P2093
P2860
P1476
A phase I study of temsirolimu ...... squamous cell cancer (HNSCC).
@en
P2093
Camelia Sima
David G Pfister
Eric Sherman
Katherine W Kelly
Matthew G Fury
Nora Katabi
Oby Nwankwo
Sofia Haque
P2860
P2888
P304
P356
10.1007/S00280-012-1894-Y
P577
2012-05-27T00:00:00Z
P6179
1009716955